Our Newsroom
This is the place to get the latest exciting news about Route 92 medical.
Route 92 Medical Receives Australian Therapeutic Goods Administration Approval for itsPortfolio of Neurovascular Interventional Products for Treating Patients with Acute Ischemic Stroke
SAN MATEO, Calif., March 27, 2025 (GLOBE NEWSWIRE) — Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced approval from the Australian Therapeutic Goods Administration (TGA) for its innovative neurovascular intervention portfolio. Within this portfolio are the first .088” super bore reperfusion systems […]
View More
First-of-its-Kind Multicenter Study Demonstrates Utility of Monopoint System in Procedures to Treat IdiopathicIntracranial Hypertension
View More
Route 92 Medical Files Patent Infringement Suit Against Q’Apel Medical
View More
Route 92 Medical Announces $50 Million Series F Extension Equity Financing
View More